2C77.1

ICD-11 MMS 2026-01

Adenocarcinoma of cervix uteri

Description

An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type.

Coding note from above levels

Includes Malignant neoplasm of skin of female genital organs

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Adenocarcinoma of cervix uteri
  • Adenoid basal carcinoma of cervix uteri
  • Adenoid cystic carcinoma of cervix uteri

Exclusions from above levels

  • 2E05.Y – Malignant neoplasm metastasis in cervix
  • 2E05 – Malignant neoplasm metastasis in female reproductive system
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
Show allHide
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2C77.0 – Squamous cell carcinoma of cervix uteri
  • 2C77.2 – Adenosquamous carcinoma of cervix uteri
  • 2C77.3 – Neuroendocrine carcinoma of cervix uteri
  • 2C77.Y – Other specified malignant neoplasms of cervix uteri
  • 2C77.Z – Malignant neoplasms of cervix uteri, unspecified

Foundation entity

Adenocarcinoma of cervix uteri – http://id.who.int/icd/entity/261293318

Allowed postcoordination axes

Part of: 2C77: Malignant neoplasms of cervix uteri › 02: Neoplasms